Patents by Inventor Yanyan CAI

Yanyan CAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230351576
    Abstract: The present disclosure relates to a half-cast mark identification and damaged flatness evaluation and classification method for blastholes in tunnel blasting, including the following steps: S1-2: photographing first and second contrast images as well as a half-cast mark image after blasting; S3-6: performing denoising, gray-scale processing and binary processing on the above images, and identifying a boundary of a half-cast mark in each of the images; S7-9: determining a flatness damage variable, a quantitative relation among an area of a half-cast mark region, the damage variable and a fractal dimension, and a damage value of the half-cast mark image; S10-11: forming five-dimensional (5D) eigenvectors to obtain multi-dimensional digital information features of the images; and S12-13: selecting eigenvectors of 60 images as training data to input to a naive Bayes classifier (NBC), and taking eigenvectors of remaining 30 images as classification data to input the above well-trained NBC for classification.
    Type: Application
    Filed: October 11, 2022
    Publication date: November 2, 2023
    Applicants: Huaqiao University, Sanming University
    Inventors: Jin YU, Xiaoqiang FU, Wei YAO, Yanyan CAI, Shiyu LIU
  • Publication number: 20170165283
    Abstract: A health care product having nicotinamide mononucleotide as the active ingredient, and the use of nicotinamide mononucleotide in preparing health care products for the prevention and treatment of arteriosclerosis and cardiovascular and cerebrovascular diseases caused by arteriosclerosis.
    Type: Application
    Filed: December 11, 2015
    Publication date: June 15, 2017
    Inventors: Rongzhao FU, Yanyan CAI
  • Publication number: 20170165282
    Abstract: A medication having nicotinamide mononucleotide as the active ingredient, and the use of nicotinamide mononucleotide in preparing medications for the prevention and treatment of arteriosclerosis and cardiovascular and cerebrovascular diseases caused by arteriosclerosis.
    Type: Application
    Filed: December 11, 2015
    Publication date: June 15, 2017
    Applicant: BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD.
    Inventors: Rongzhao FU, Yanyan CAI